Citation Impact
Citing Papers
Staging and grading of periodontitis: Framework and proposal of a new classification and case definition
2018 Standout
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Acute kidney injury
2012 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Statins in tumor suppression
2008
Nucleotide signalling during inflammation
2014 StandoutNature
On the Clinical Pharmacology of Reactive Oxygen Species
2020
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Complement-Mediated Ischemia-Reperfusion Injury
2009
Pronóstico intrahospitalario de la hemoglobina en pacientes con síndrome coronario agudo
2008
Urinary Excretion of Liver-Type Fatty Acid–Binding Protein in Contrast Medium–Induced Nephropathy
2006
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Plasma adiponectin levels and clinical outcomes among haemodialysis patients
2008
Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes
2008
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Glycoprotein IIb/IIIa and P2Y12receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses
2005
Adipokines in inflammation and metabolic disease
2011 Standout
Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use
2009
Acute kidney injury
2019 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling
2017
p21 in cancer: intricate networks and multiple activities
2009 Standout
Cardiorenal Syndrome
2008 Standout
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
1998
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation
2008
Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy
2009
Platelets and the immune continuum
2011 Standout
Autologous platelets as a source of proteins for healing and tissue regeneration
2003 Standout
Adiponectin: mechanistic insights and clinical implications
2012
Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial
2004
Neutrophils, from Marrow to Microbes
2010 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
2010
Reactive oxygen species in cardiovascular disease
2011
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
What We Talk About When We Talk About Fat
2014 Standout
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Adiponectin, driver or passenger on the road to insulin sensitivity?
2013
Role of antiplatelet drugs in the prevention of cardiovascular events
2003
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel
2006
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
The Inflammatory Preatherosclerotic Remodeling Induced by Intermittent Hypoxia Is Attenuated by RANTES/CCL5 Inhibition
2011
Evidence that periodontal treatment improves biomarkers and CVD outcomes
2013
Nouvelle Cuisine: Platelets Served with Inflammation
2015
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Soluble CD40 Ligand in Pulmonary Arterial Hypertension
2004
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 Standout
The pathophysiology of acute coronary syndromes
2000
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Plasma levels of trimethylamine-N-oxide can be increased with ‘healthy’ and ‘unhealthy’ diets and do not correlate with the extent of atherosclerosis but with plaque instability
2020
Does body mass index truly affect mortality and cardiovascular outcomes in patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft? A systematic review and network meta‐analysis
2018
Influence of Hemoglobin Level on In-Hospital Prognosis in Patients With Acute Coronary Syndrome
2008
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
Mechanisms of Plaque Formation and Rupture
2014 Standout
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases
2009
Heavily Calcified Coronary Lesions Preclude Strut Apposition Despite High Pressure Balloon Dilatation and Rotational Atherectomy In-Vivo Demonstration With Optical Coherence Tomography
2007
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Mechanisms of Diabetic Complications
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Chemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: A review.
2008
Determinants of Serum High Molecular Weight (HMW) Adiponectin Levels in Patients with Coronary Artery Disease: Associations with Cardio-renal-anemia Syndrome
2011
Lack of Association Between Adiponectin Levels and Atherosclerosis in Mice
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Inflammation and metabolic dysfunction: links to cardiovascular diseases
2012
Works of Erdal Çavuşoğlu being referenced
Neutrophil to Lymphocyte Ratio as a Predictor of Long‐term Mortality in African Americans Undergoing Percutaneous Coronary Intervention
2009
Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
2009
Clopidogrel in the Management of Ischemic Heart Disease
2003
Usefulness of Anemia in Men as an Independent Predictor of Two-Year Cardiovascular Outcome in Patients Presenting With Acute Coronary Syndrome
2006
Unstable Angina Pectoris and Non-Q-Wave Myocardial Infarction
2001
Usefulness of the Serum Complement Component C4 as a Predictor of Stroke in Patients With Known or Suspected Coronary Artery Disease Referred for Coronary Angiography
2007
The Role of Clopidogrel in the Management of Patients with Ischemic Heart Disease
2003
Vesnarinone: A new inotropic agent for treating congestive heart failure
1995
Contrast-Associated Nephropathy
2002
Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome
2007
Comparison of Platelet Function and Morphology in Patients Undergoing Percutaneous Coronary Intervention Receiving Bivalirudin Versus Unfractionated Heparin Versus Clopidogrel Pretreatment and Bivalirudin
2007
Association of Plasma Levels of F11 Receptor/Junctional Adhesion Molecule-A (F11R/JAM-A) With Human Atherosclerosis
2007
Current status of rotational atherectomy
2004
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
2006
Plasma Interleukin-10 Levels and Adverse Outcomes in Acute Coronary Syndrome
2011
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
2006
Beyond Lipid Lowering: The Anti-Hypertensive Role of Statins
2007
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
2007
The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
2004
Membrane-associated CD40L and sCD40L in atherothrombotic disease
2003
High-dose tirofiban administered as bolus-only during percutaneous coronary intervention.
2008
Impact of body mass index on long-term all-cause mortality after percutaneous coronary intervention in African-Americans.
2009
Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention.
2006
The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration.
2005